Here it is -- on an amended SEC Form 13G:
. . . .February 17, 2009: 210,245,110 shares or 12.93%. . . .
February 14, 2008: 190,544,131 shares or 11.76%. . . .
February 14, 2006: 156,897,180 shares or 10.62%. . . .
Odd -- it looks like Wellington picked up about what CRMC reported shedding. Ironic.
2 comments:
I believe Wellington was also one of the primary shareholders of Lilly when Zyprexa (asenapine's brother) was approved and Wellington was the major shareholder of Pharmacia when Fred sold to Pfizer.
You may want to look into Wellington's positions at other companies when Fred was heading them up.
Salmon
PS I haven't forgotten about commenting about Fred's timing of his stock purchases in 2008.
Salmon
Post a Comment